Friedrich Max J, Wimmer Matthias D, Schmolders Jan, Strauss Andreas C, Ploeger Milena M, Kohlhof Hendrik, Wirtz Dieter C, Gravius Sascha, Randau Thomas M
Max J Friedrich, Matthias D Wimmer, Jan Schmolders, Andreas C Strauss, Milena M Ploeger, Hendrik Kohlhof, Dieter C Wirtz, Sascha Gravius, Thomas M Randau, Department of Orthopedics and Trauma Surgery, University Clinic of Bonn, 53125 Bonn, Germany.
World J Orthop. 2017 Apr 18;8(4):342-349. doi: 10.5312/wjo.v8.i4.342.
To assess serum levels of RANK-ligand (RANKL) and osteoprotegerin (OPG) as biomarkers for periprosthetic joint infection (PJI) and compare their accuracy with standard tests.
One hundred and twenty patients presenting with a painful total knee or hip arthroplasty with indication for surgical revision were included in this prospective clinical trial. Based on standard diagnostics (joint aspirate, microbiological, and histological samples) and Musculoskeletal Infection Society consensus classification, patients were categorized into PJI, aseptic loosening, and control groups. Implant loosening was assessed radiographically and intraoperatively. Preoperative serum samples were collected and analyzed for RANKL, OPG, calcium, phosphate, alkaline phosphatase (AP), and the bone-specific subform of AP (bAP). Statistical analysis was carried out, testing for significant differences between the three groups and between stable and loose implants.
All three groups were identical in regards to age, gender, and joint distribution. No statistically significant differences in the serum concentration of RANKL ( = 0.16) and OPG ( = 0.45) were found between aseptic loosening and PJI, with a trend towards lower RANKL concentrations and higher OPG concentrations in the PJI group. The RANKL/OPG ratio was significant for the comparison between PJI and non-PJI ( = 0.005). A ratio > 60 ruled out PJI in all cases (specificity: 100%, 95%CI: 89, 11% to 100.0%) but only 30% of non-PJI patients crossed this threshold. The positive predictive value remained poor at any cut-off. In the differentiation between stable and loose implants, none of the parameters measured (calcium, phosphate, AP, and bAP) showed a significant difference, and only AP and bAP measurements showed a tendency towards higher values in the loosened group (with = 0.09 for AP and = 0.19 for bAP).
Lower RANKL and higher OPG concentrations could be detected in PJI, without statistical significance.
评估血清中核因子κB受体活化因子配体(RANKL)和骨保护素(OPG)水平作为假体周围关节感染(PJI)生物标志物的价值,并将其准确性与标准检测方法进行比较。
本前瞻性临床试验纳入了120例因全膝关节或髋关节置换术后疼痛且有手术翻修指征的患者。根据标准诊断方法(关节穿刺液、微生物学和组织学样本)以及肌肉骨骼感染学会的共识分类,将患者分为PJI组、无菌性松动组和对照组。通过影像学和术中评估植入物松动情况。术前采集血清样本,分析其中RANKL、OPG、钙、磷、碱性磷酸酶(AP)以及骨特异性碱性磷酸酶(bAP)的水平。进行统计学分析,检验三组之间以及稳定和松动植入物之间的显著差异。
三组在年龄、性别和关节分布方面相同。无菌性松动组和PJI组之间,RANKL(P = 0.16)和OPG(P = 0.45)的血清浓度无统计学显著差异,PJI组有RANKL浓度较低和OPG浓度较高的趋势。RANKL/OPG比值在PJI组和非PJI组之间的比较中有显著意义(P = 0.005)。比值> 60在所有病例中均可排除PJI(特异性:100%,95%CI:89.11%至100.0%),但只有30%的非PJI患者超过此阈值。在任何临界值下,阳性预测值均较差。在区分稳定和松动植入物时,所测量的参数(钙、磷、AP和bAP)均无显著差异,只有AP和bAP测量值在松动组中有升高的趋势(AP的P = 0.09,bAP的P = 0.19)。
在PJI中可检测到较低的RANKL和较高浓度的OPG,但无统计学意义。